Article: Landmark Global Survey of People Living with HIV and AIDS Shows Concerning Results that Side Effects are Leading Cause for U.S. Respondents to Discontinue or Switch Treatment Regimens.

Despite 25 Years of Pandemic, U.S. Respondents Are Still Concerned about Stigma and Discrimination

MEXICO CITY, Aug. 4 /PRNewswire/ -- Results from the groundbreaking AIDS Treatment for Life International Survey (ATLIS), which polled nearly 3,000 HIV-positive patients from 18 countries, show that a concerning number of people living with HIV and AIDS in the United States (U.S.) discontinue or switch treatment regimens due to apprehension or experience with side effects resulting from antiretroviral (ARV) drugs. ATLIS findings also reveal that people living with HIV and AIDS in the U.S. still live in fear of the societal stigma and discrimination that surround ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!